Tag: NDRM

Blue Horseshoe Stocks: Final Report of 2014

Good Morning Traders! Here it is- the final report of 2014! We had an amazing year, with huge gainers popping out of the woodwork left, right, and center! We want to take this opportunity to thank all of our readers for being a part of our community, wish you all a Happy New Year while reminding everyone that the best is yet to come… Each year our resolution remains the same: To make the upcoming year our best one ever! We’ve succeeded time and time again, and have no reason to believe that 2015 will be any different so be sure to stay with us! Cheers!

NeuroDerm Ltd. NDRM
NDRM exceeded all expectations yesterday after we caught it on an early morning news scan; it spent the entire day in full-on breakout mode setting records in both price and volume, trading almost 27X the norm over the six week period since the stock’s IPO.

Positive response to yesterday’s early morning press statement hurtled NDRM from an early low of 8.16 all the way up to 19.07 just prior to the close, making gains of up to 134% possible.

We’ll still be standing at the ready for an eventual course correction and chance for a dip-and-rip maneuver, but any way you slice it, NDRM is getting marked down as a huge winner. It’s a great way to close out what has, on the whole, been an absolutely stellar year.

NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson’s Disease (Tue 7:00AM EST)

Precious Metals on Watch: Gold, Silver

GDX and SLV have each been maintaining higher highs and higher lows since reaching a bottom in November. As we head into the New Year, we’re going to devote a good amount of focus to gold and silver, and tracking these indices and their options chains is going to be a good way to do that.

In particular, we’re going to be monitoring a few specific sets of contracts for each play:

  SLV – March $15-15.50 Calls

GDX – March $17.50-$18 Calls

As you can see from the side-by-side chart we drew up below, GDX and SLV are looking similarly ripe. We’ve got SLV breaking the 50-Line on the RSI, and GDX following closely behind in that regard, we’re seeing testing of the 50DMA’s on both charts, and each of the MACD’s are giving the indication of bullish crosses.

Side Note:
We’re also going to radar HMCP, a sub-penny momentum play that has had an interesting past few sessions.

Extended Watchlist:
NRX, RDHL, MIG, CYTK, NEON, BCLI, CVEO

Blue Horseshoe Stocks: WATT Recap, NDRM & More

Energous Corp.  WATT

We first began tracking WATT on Wednesday of last week, and on that day we witnessed a low of 8.40. Yesterday, just three sessions later, the stock bullrushed its way to a high of 11.20, a highly respectable three-day increase of 33%

This is one that will remain on our watchlist heading into this week’s holiday break, and in order for us to remain interested we’ll want to see the stock maintain support in the  9.60-10.75 range.

Amazon.com, Inc. AMZN – Options Idea

AMZN started flirting with the 50 DMA ($311) getting above it yesterday for the first time in a few weeks. Chart conditions are ripe with RSI just getting above the 50 line and the MACD having just underwent a bullish cross as we point out in the snapshot below.

As a result of these conditions, we want to radar the January 17th $300-315 Calls which closed yesterday at 15.62 and 6.53 respectively.

NeuroDerm Ltd. NDRM

NDRM, having just come off of a relative bottom, is flying high in the premarket this morning, gapping up to tune of 30% The company announced enccouraging top-line results for one of their treatments currently in testing, and the reaction is being felt on the chart.

We will be looking at this play the way we do most stock that are surging hard on news; observing for profit-takers to cause a pullback off of the top, and a dip-and-rip where we can take advantage of the subsequent rebound.

TODAY’S NEWS:

Extended Watchlist:
BGMD, CJJD, XNPT, ARCP, ANV